• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Elevation of creatine kinase is associated with worse outcomes in 2009 pH1N1 influenza A infection

tetano

Editor, Senior Moderator
Intensive Care Med. 2012 Apr 18. [Epub ahead of print]
Elevation of creatine kinase is associated with worse outcomes in 2009 pH1N1 influenza A infection.
Borgatta B, P?rez M, Vidaur L, Lorente L, Soc?as L, Pozo JC, Garnacho-Montero J, Rello J.
Source

Critical Care Department, Vall D'Hebron University Hospital, Universitat Aut?noma de Barcelona (UAB), 08035, Barcelona, Spain, borgatta@crips.es.
Abstract
BACKGROUND:

Current medical knowledge lacks specific information regarding creatine kinase (CK) elevation in influenza A pH1N1 (2009) infection.
OBJECTIVES:

Primary endpoints were correlation between CK at intensive care unit (ICU) admission and ICU mortality. Secondary endpoints were ICU length of stay (LOS), mechanical ventilation (MV), and requirement of renal replacement techniques (RRT).
MATERIALS AND METHODS:

A prospective multicenter register included all adults admitted for severe acute respiratory insufficiency (SARI) with confirmed pH1N1 in 148 ICUs. Clinical data including demographics, comorbidities, laboratory information, organ involvement, and prognostic data were registered. Post hoc classification of subjects was determined according to CK level. Data are expressed as median (interquartile range).
RESULTS:

Five hundred and five (505) patients were evaluable. Global ICU mortality was 17.8 % without documented differences between breakpoints. CK ≥500 UI/L was documented in 23.8 % of ICU admissions, being associated with greater renal dysfunction: acute kidney injury (AKI) was more frequent (26.1 versus 17.1 %, p < 0.05) and twofold requirement of RRT [11 versus 5.6 %, p < 0.05; odds ratio (OR) = 2.09 (95 % confidence interval [CI] 1.01-4.32)]. Increase of CK ≥1,000 UI/L was associated with two or more quadrant involvement on chest X-ray (63.2 versus 40.2 %, p < 0.01) and increased intubation risk (73.9 versus 56.7 %, p = 0.07) and duration of mechanical ventilation (median 15 days versus 11 days, p < 0.01). As a result, CK ≥1,000 UI/L was associated with 5 extra days of ICU and hospital LOS.
CONCLUSIONS:

CK is a biomarker of severity in pH1N1 infection. Elevation of CK was associated with more complications and increased ICU LOS and healthcare resources.

PMID:
22527080
[PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/22527080
 
Re: Elevation of creatine kinase is associated with worse outcomes in 2009 pH1N1 influenza A infection

Intensive Care Med. 2012 Jun 27. [Epub ahead of print]
Erratum to: Elevation of creatine kinase is associated with worse outcomes in 2009 pH1N1 influenza A infection.
Borgatta B, P?rez M, Vidaur L, Lorente L, Soc?as L, Pozo JC, Garnacho-Montero J, Rello J; The pH1N1 GTEI/SEMICYUC Investigators.
Source

Critical Care Department, Vall D'Hebron University Hospital, Universitat Aut?noma de Barcelona (UAB), 08035, Barcelona, Spain, borgatta@crips.es.

PMID:
22735857
[PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/22735857
 
Back
Top Bottom